Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theo Dingermann

Showing results (81-90 of 85) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 85 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2009
An interstitial deletion at 3p21.3 results in the genetic fusion of MLH1 and ITGA9 in a Lynch syndrome familyClaus Meyer, Angela Brieger, Guido Plotz, et al.
Cancer Genetics|December 6, 2011
A complex MLL rearrangement identified five years after initial MDS diagnosis results in out-of-frame fusions without progression to acute leukemiaClaus Meyer, Eric Kowarz, Sze-Fai Yip, et al.
Leukemia|April 6, 2007
Complex MLL rearrangements in t(4;11) leukemia patients with absent AF4.MLL fusion alleleE Kowarz, T Burmeister, L Lo Nigro, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 2005
Diagnostic tool for the identification of MLL rearrangements including unknown partner genesClaus Meyer, Bjoern Schneider, Martin Reichel, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 24, 2022
Use of follow-on disease-modifying treatments for multiple sclerosis: Consensus recommendationsWallace J Brownlee, Christian Wolf, Hans-Peter Hartung, et al.
Pageof 9

Showing results (81-90 of 85) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 85 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2009
An interstitial deletion at 3p21.3 results in the genetic fusion of MLH1 and ITGA9 in a Lynch syndrome familyClaus Meyer, Angela Brieger, Guido Plotz, et al.
Cancer Genetics|December 6, 2011
A complex MLL rearrangement identified five years after initial MDS diagnosis results in out-of-frame fusions without progression to acute leukemiaClaus Meyer, Eric Kowarz, Sze-Fai Yip, et al.
Leukemia|April 6, 2007
Complex MLL rearrangements in t(4;11) leukemia patients with absent AF4.MLL fusion alleleE Kowarz, T Burmeister, L Lo Nigro, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 2005
Diagnostic tool for the identification of MLL rearrangements including unknown partner genesClaus Meyer, Bjoern Schneider, Martin Reichel, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 24, 2022
Use of follow-on disease-modifying treatments for multiple sclerosis: Consensus recommendationsWallace J Brownlee, Christian Wolf, Hans-Peter Hartung, et al.
Pageof 9